Literature DB >> 21562750

PWI-MRI and contrast extravasation in brain AVM help to estimate angiogenic activity.

Guillaume Saliou1, Timo Krings, Dik R Rutgers, Frederique Toulgoat, Augustin Ozanne, Pierre Lasjaunias, Denis Ducreux.   

Abstract

INTRODUCTION: The aim of this study is to investigate perfusion characteristics of brain arteriovenous malformation (AVM) by means of MRI perfusion-weighted imaging (PWI).
METHODS: Forty-three patients with brain AVM were prospectively included and investigated by PWI-MRI. Diagnosis of type of disease was made by angiogram. According to angiographic features, the study group was classified in three groups: two groups of patients with classical AVM (group 1 with few or no angiogenic feature (13 patients) and group 2 with many angiogenic features (18 patients)) and one group (group 3) which included patients with cerebral proliferative angiopathy (CPA; 12 patients). Twenty-one patients had never been treated endovascularly for their AVM and 22 patients received partial treatment by endovascular embolisation. Through PWI, corrected cerebral blood volume (CBVc), mean transit time (MTT), and percentage of microvascular leakage (MVL) as an indirect measure of permeability were assessed.
RESULTS: The three patient groups did not differ significantly in baseline and clinical parameters. CBVc, MTT, and MVL differed significantly between the three groups (p = 0.003, p = 0.04, p = 0.01, respectively), with the lowest mean values found in group 1 and the highest in group 3. Mean MVL was 11.4 in group 1, 18.6 in group 2, and 21.9 in group 3.
CONCLUSION: MRI can demonstrate differences in PWI parameters among patients with classical AVM and CPA, which are related to angiographic features of these AVMs. Through PWI, the level of angiogenic activity in AVMs may be monitored.

Entities:  

Mesh:

Year:  2011        PMID: 21562750     DOI: 10.1007/s00234-011-0882-y

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  33 in total

1.  Expression of integrins in cerebral arteriovenous and cavernous malformations.

Authors:  Aşkin Seker; Ozlem Yildirim; Ozlem Kurtkaya; Aydin Sav; Murat Günel; M Necmettin Pamir; Türker Kiliç
Journal:  Neurosurgery       Date:  2006-01       Impact factor: 4.654

2.  Perfusion-weighted MR imaging studies in brain hypervascular diseases: comparison of arterial input function extractions for perfusion measurement.

Authors:  D Ducreux; I Buvat; J F Meder; D Mikulis; A Crawley; D Fredy; K TerBrugge; P Lasjaunias; J Bittoun
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

3.  Interleukin-6 involvement in brain arteriovenous malformations.

Authors:  Yongmei Chen; Ludmila Pawlikowska; Jianhua S Yao; Fanxia Shen; Wenwu Zhai; Achal S Achrol; Michael T Lawton; Pui-Yan Kwok; Guo-Yuan Yang; William L Young
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

4.  Expression of vascular endothelial growth factor in pediatric and adult cerebral arteriovenous malformations: an immunocytochemical study.

Authors:  W J Sonstein; A Kader; W J Michelsen; J F Llena; A Hirano; D Casper
Journal:  J Neurosurg       Date:  1996-11       Impact factor: 5.115

5.  Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM.

Authors:  H J Meisel; U Mansmann; H Alvarez; G Rodesch; M Brock; P Lasjaunias
Journal:  Acta Neurochir (Wien)       Date:  2002-09       Impact factor: 2.216

6.  Cerebral arteriovenous malformations and associated aneurysms: analysis of 305 cases from a series of 662 patients.

Authors:  H J Meisel; U Mansmann; H Alvarez; G Rodesch; M Brock; P Lasjaunias
Journal:  Neurosurgery       Date:  2000-04       Impact factor: 4.654

7.  Dynamic contrast-enhanced MRI using macromolecular contrast media for monitoring the response to isolated limb perfusion in experimental soft-tissue sarcomas.

Authors:  A Preda; P A Wielopolski; T L M Ten Hagen; M van Vliet; J F Veenland; G Ambagtsheer; S T van Tiel; M W Vogel; A M M Eggermont; G P Krestin; C F van Dijke
Journal:  MAGMA       Date:  2004-10-10       Impact factor: 2.310

8.  Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy.

Authors:  Mark M Moasser; Lisa J Wilmes; Ching Hang Wong; Sheye Aliu; Ka-Loh Li; Donghui Wang; Yun Kit Hom; Byron Hann; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2007-12       Impact factor: 4.813

9.  Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights.

Authors:  Karl Turetschek; Anda Preda; Viktor Novikov; Robert C Brasch; Hanns J Weinmann; Patrick Wunderbaldinger; Timothy P L Roberts
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

10.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade.

Authors:  H C Roberts; T P Roberts; R C Brasch; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  5 in total

1.  Brain arteriovenous malformation diagnosis: value of time-resolved contrast-enhanced MR angiography at 3.0T compared to DSA.

Authors:  A Machet; C Portefaix; K Kadziolka; G Robin; O Lanoix; L Pierot
Journal:  Neuroradiology       Date:  2012-03-13       Impact factor: 2.804

2.  Measurement of blood flow in arteriovenous malformations before and after embolization using arterial spin labeling.

Authors:  L Suazo; B Foerster; R Fermin; H Speckter; C Vilchez; J Oviedo; P Stoeter
Journal:  Interv Neuroradiol       Date:  2012-03-16       Impact factor: 1.610

Review 3.  The Applicability of Amide Proton Transfer Imaging in the Nervous System: Focus on Hypoxic-Ischemic Encephalopathy in the Neonate.

Authors:  Yang Zheng; Xiaoming Wang
Journal:  Cell Mol Neurobiol       Date:  2017-09-23       Impact factor: 5.046

4.  Atypical MRI features in soft-tissue arteriovenous malformation: a novel imaging appearance with radiologic-pathologic correlation.

Authors:  Anand S Patel; Joshua M Schulman; Beth S Ruben; William Y Hoffman; Christopher F Dowd; Ilona J Frieden; Christopher P Hess
Journal:  Pediatr Radiol       Date:  2015-04-28

Review 5.  Multinuclear MRI in Drug Discovery.

Authors:  Dorota Bartusik-Aebisher; Zuzanna Bober; Jolanta Zalejska-Fiolka; Aleksandra Kawczyk-Krupka; David Aebisher
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.